These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3437831)

  • 1. [Conservative therapy of echinococcal disease: optimization of the mebendazole dosage regimen using a computer].
    Lur'e AA; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (5):13-6. PubMed ID: 3437831
    [No Abstract]   [Full Text] [Related]  

  • 2. [The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1993; (1):43-5. PubMed ID: 8336653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of the possibility of increasing the bioavailability of mebendazole using sunflower oil in echinococcosis].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1989; (3):46-9. PubMed ID: 2674643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability].
    Dzhabarova VI; Dobrotvorskiĭ AE; Krotov AI
    Med Parazitol (Mosk); 1989; (5):43-6. PubMed ID: 2615711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental chemotherapy of alveococcosis. 9. The pharmacokinetics and effectiveness of mebendazole when administered by peroral and intramuscular routes to infected mice].
    Dzhabarova VI; Lur'e AA; Krotov AI
    Med Parazitol (Mosk); 1986; (5):63-7. PubMed ID: 3796458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].
    Liu CS; Zhang HB
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):513-9. PubMed ID: 20232637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of plant oils to increase the bioavailability of mebendazole (in a model of larval unilocular echinococcosis)].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1987; (2):19-22. PubMed ID: 3600502
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):67-71. PubMed ID: 3796459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hepatic and intra-abdominal hydatidosis with mebendazole: prospective comparison of the cyclic and the continuous regimen].
    Gil Grande LA; Sánchez Ruano JJ; López San Román A; García-Hoz F; Barcena R; Salinas F
    Rev Esp Enferm Dig; 1993 Dec; 84(6):386-9. PubMed ID: 8129993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of high-dosage mebendazole chemotherapy in echinococcosis].
    Kern P; Dietrich M
    Aktuelle Probl Chir Orthop; 1982; 23():104-5. PubMed ID: 6124149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of human echinococcosis].
    Bähr R; Ammann R; Bircher J; Eckert J
    Chirurg; 1984 Feb; 55(2):114-6. PubMed ID: 6714007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the chemotherapy of echinococcosis using intramuscular injections of a mebendazole suspension].
    Krotov AI; Dzhabarova VI; Pereverzeva EV; Lopatin BV; Dobrotvorskiĭ AE
    Med Parazitol (Mosk); 1983; (5):61-3. PubMed ID: 6646057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of echinococcosis in humans with mebendazole].
    Ammann R; Müller E; Akovbiantz A; Bircher J; Eckert J; Wissler K; Witassek F; Wüthrich B; Woodtli W
    Aktuelle Probl Chir Orthop; 1982; 23():92-5. PubMed ID: 6124170
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the intraperitoneal administration of mebendazole on the immune reactions of mice with experimental hydatid disease].
    Kovrova EA; Frol'tsova AE; Leĭkina ES; Krotov AI
    Med Parazitol (Mosk); 1979; 48(1):78-82. PubMed ID: 431502
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results.
    Münst GJ; Karlaganis G; Bircher J
    Eur J Clin Pharmacol; 1980 May; 17(5):375-8. PubMed ID: 7418715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease.
    Bryceson AD; Woestenborghs R; Michiels M; van den Bossche H
    Trans R Soc Trop Med Hyg; 1982; 76(4):563-4. PubMed ID: 6926777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Optimization of the chemotherapy of echinococcal disease (the current state of the problem and the means for its resolution)].
    Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):57-61. PubMed ID: 3540558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiment studies in the treatment of echinococcosis with mebendazole (Vermox)].
    Stojanov G; Yurukova D; Bakardjiev T
    Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):285-9. PubMed ID: 6506828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mebendazole treatment of patients with alveolar echinococcosis].
    Shcherbakov AM; Panteleeva EIa; Firsova RA
    Med Parazitol (Mosk); 1993; (2):14-6. PubMed ID: 8028556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cystic hydatid disease: treatment with interrupted courses of mebendazole.
    Mousa AM; Rudwan MA; Marafi AA; Muhtaseb SA; Dajani AI
    J Trop Med Hyg; 1986 Oct; 89(5):257-64. PubMed ID: 3795326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.